ArticlePharmaceutics2022

Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors.

Weiming You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.